Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.

Saved in:
Bibliographic Details
Title: Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Authors: Pallocca M; Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy. matteo.pallocca@cnr.it., Molineris I; Department of Life Science and System Biology, University of Turin, Via Accademia Albertina 13, 10123, Naples, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Berrino E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; University of Turin, Turin, Italy., Marcozzi B; Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Betti M; Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Levati L; Laboratory of Molecular Oncology, IDI-IRCCS, Rome, Italy., D'Atri S; Laboratory of Molecular Oncology, IDI-IRCCS, Rome, Italy., Menin C; Immunology and Oncological Molecular Diagnostics, Oncological Institute, IOV IRCCS UOC, Padua, Italy., Madonna G; Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy., Ghiorzo P; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.; Department of Internal Medicine and Medical Specialties, University of Genova, 16132, Genoa, Italy., Bulgarelli J; Immunotherapy, Cell Therapy and Biobank Unit, IRCCS Istituto Romagnolo Per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy., Ferraresi V; Sarcoma and Rare Tumours Departmental Unit- IRCCS Regina Elena National Cancer Institute-Rome, Rome, Italy., Venesio T; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Rodolfo M; Unit of Translational Immunology, Department of Experimental Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy., Rivoltini L; Unit of Translational Immunology, Department of Experimental Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy., Lanfrancone L; Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy., Mazzarella L; Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy., Pelicci PG; Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., De Maria R; Institute of General Pathology, Catholic University 'Sacro Cuore', Rome, Italy., Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Medico E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Russo G; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Source: Journal of translational medicine [J Transl Med] 2024 Oct 22; Vol. 22 (1), pp. 958. Date of Electronic Publication: 2024 Oct 22.
Publication Type: Published Erratum
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1479-5876
DOI:10.1186/s12967-024-05717-3